Craft

NewGLAB Pharma

Stock Price

₩6.9 K

2024-10-29

Market Capitalization

₩64.7 B

2024-07-19

Revenue

₩12.6 B

FY, 2023

NewGLAB Pharma Summary

Company Summary

Overview
NewGLAB Pharma is a company engaged in the pharmaceutical, surveillance, and distribution businesses. It is engaged in the production and distribution of pharmaceuticals, drug development, distribution of consumer electronics, closed-circuit television (CCTV) camera supply, and other activities through its business divisions.
Type
Public
Status
Active
Founded
2004
Website
http://www.newglab.com
Cybersecurity rating
Sectors

Table of Contents

NewGLAB Pharma Financials

Summary Financials

Revenue (Q3, 2024)
₩1.8B
Gross profit (Q3, 2024)
₩179.4M
Net income (Q3, 2024)
(₩1.8B)
Cash (Q3, 2024)
₩625.1M
EBIT (Q3, 2024)
(₩1.9B)
Enterprise value
$23.6B

Footer menu